Publicaciones
-
Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study
British Journal of Dermatology, 2024;, ljae454, https://doi.org/10.1093/bjd/ljae454
Duc Binh Phan, Hugo Jourdain, Miguel Angel Descalzo-Gallego, Alicia González-Quesada, Mahmoud Zureik, Raquel Rivera-Díaz, et al.
-
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
Br J Dermatol 2023.
Lluch-Galcera JJ, Carrascosa JM, Gonzalez-Quesada A, Rivera-Diaz R, Sahuquillo-Torralba A, Llamas-Velasco M et al
Descargar documento
-
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.
BMJ Open. 2023 Jul 14;13(7):e075197
Phan DB, Jourdain H, González-Quesada A, Zureik M, Rivera-Díaz R, Sahuquillo-Torralba A, Descalzo-Gallego MA, Lunt M, Garcia-Doval I, Sbidian E, Warren RB, Yiu ZZN.
Descargar documento
-
Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the BIOBADADERM registry.
Br J Dermatol. 2022;187(5):817-20.
Ruiz Genao DP, Carretero G, Rivera-Diaz R, Carrascosa JM, Sahuquillo-Torralba A, Herrera-Acosta E, García FJG, Daudén E, Estebaranz JLL, Garcia-Doval I; BIOBADADERM Study Group.
Descargar documento
-
Epidemiology and Geographic Distribution of Generalized Pustular Psoriasis in Spain: A National Population-Based Study of Hospital Admissions from 2016 to 2020.
Actas Dermosifiliogr. 2023;114(2):97-101.
Montero-Vilchez T, Grau-Perez M, Garcia-Doval I.
Descargar documento
-
Erythrodermic Psoriasis Has Become Less Frequent: Results From the Biobadaderm Registry.
Actas Dermosifiliogr. 2023;114(4):T366-T9.
Rivera-Diaz R, Carretero G, Carrascosa JM, Garcia-Doval I.
Descargar documento
-
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience
Actas Dermosifiliogr 2022; 113: 401-6
Nieto Benito LM, Carretero G, Rivera-Díaz R, Carrascosa JM, Daudén E, de la Cueva P, Sahuquillo-Torralba A, Herrera-Acosta E, Baniandrés-Rodríguez O, Lopez-Estebaranz JL, Belinchón I, Riera-Monroig J, Ferrán M, Gómez-García FJ, Mateu A, Rodríguez L, Vilar-Alejo J, García-Donoso C, Ballescá F, Velasco LM, Botella-Estrada R, Herrera-Ceballos E, Ruiz-Genao DP, Descalzo MA, García-Doval I; el grupo de estudio BIOBADADERM.
Descargar documento
-
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) breastfeed less when compared with general population.
J Eur Acad Dermatol Venereol 2022; 36: e205-e7.
R Rivera-Diaz, M Llamas-Velasco, G Carretero, D Ruíz-Genao, I Belinchón, J Riera-Monroig, P de la Cueva, M Ferrán, M de Vega, I García-Doval
Descargar documento
-
The risk of hepatic adverse events of systemic medications for psoriasis: A prospective cohort study using the BIOBADADERM registry
Journal of Dermatological Treatment 2021 DOI: 10.1080/09546634.2021.1922572
M. Munera-Campos, M.D., O Baniandrés-Rodríguez, M.D., Ph.D. , J Vilar-Alejo, M.D. , R Rivera, M.D. , JM Carrascosa, M.D., Ph.D. , E Daudén, M.D., Ph.D. , E Herrera-Acosta, M.D., Ph.D. , A Sahuquillo-Torralba, M.D. , FJ Gómez-García, M.D. , LM Nieto-Benito , M.D. , P de la Cueva, M.D., Ph.D. , JL López-Estebaranz, M.D., Ph.D , I Belinchón, M.D., Ph.D. , M Ferrán, M.D., Ph.D. , M Alsina, M.D., Ph.D. , L Rodriguez, M.D. , G Carretero, M.D., Ph.D. , C García-Donoso, M.D. , F Ballescá, M.D. , M Llama
Descargar documento
-
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
Acta Derm Venereol . 2020 Dec 3. doi: 10.2340/00015555-3711 https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3711
Carlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, Carlos Ferrándiz, Esteban Daudén, Pablo de la Cueva, Isabel Belinchón, Francisco Javier Gómez-García, Enrique Herrera-Acosta, Diana P Ruiz-Genao, Marta Ferrán, Mercé Alsina, Ofelia Baniandrés-Rodríguez, José Luis Sánchez-Carazo, Rafael Botella-Estrada, Antonio Sahuquillo-Torralba, Lourdes Rodríguez, Jaime Vilar-Alejo, Carmen García-Donoso, José M Carrascosa, Mar Llamas-Velasco, Enrique Herrera-Ceballos, Jose Luis López-Estebar
Descargar documento
-
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis.
J Am Acad Dermatol. 2020 Oct 26:S0190-9622(20)32858-9. doi: 10.1016/j.jaad.2020.10.046
Baniandrés-Rodríguez O, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Nieto-Benito LM, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferrán M, Alsina M, Rodriguez L, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Ruiz-Genao DP, Riera-Monroig J, Descalzo MA, García-Doval I; BIOBADADERM Study Group.
Descargar documento
-
Cambios en las tendencias de la prescripción y causas de la interrupción en los tratamientos biológicos indicados en la psoriasis durante los primeros 10 años. Datos obtenidos del registro español Biobadaderm
Actas Dermosifiliogr . 2020 Oct 12;S0001-7310(20)30375-6. doi: 10.1016/j.ad.2020.05.008.
Ruiz-Genao DP, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Belinchón I, Gómez-García FJ, Herrera-Acosta E, López-Estebaranz JL, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo JL, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo MA, García-Doval I;en nombre del grupo BIOBADADERM.
Descargar documento
-
Long-term Safety of Nine Systemic Medications for Psoriasis: A Cohort Study Using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
J Am Acad Dermatol . 2020 Jul;83(1):139-150
Esteban Dauden, MD, PhD, Gregorio Carretero, MD, PhD, Raquel Rivera, MD, Carlos Ferrandiz, MD, PhD, Mar Llamas-Velasco, MD, PhD, Pablo de la Cueva, MD, PhD, Isabel Belinchon, MD, PhD, Francisco Jose Gomez-Garcia, MD, PhD, Enrique Herrera-Acosta, MD, PhD, Diana Patricia Ruiz-Genao, MD, Marta Ferran-Farres, MD, PhD, Merce Alsina, MD, PhD, Ofelia Baniandres-Rodriguez, MD, PhD, Jose Luis Sanchez-Carazo, MD, PhD, Antonio Sahuquillo-Torralba, MD, et al.
Descargar documento
-
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm registry: a prospective cohort study.
J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32388-6. doi: 10.1016/j.jaad.2019.07.028.
Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Acosta E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Rodriguez L, Vilar J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, López-Estebaranz JL, Pujol-Marco C, Descalzo MA, García-Doval I; Biobadaderm Study Group.
Descargar documento
-
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population.
Dermatol. 2019 May 25. doi: 10.1111/bjd.18164.
Gonzalez-Cantero A, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Ceballos E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Sahuquillo-Torralba A, Rodriguez L, Vilar J, García C, Carrascosa JM, Llamas-Velasco M, Herrera-Acosta E, López-Estebaranz JL, Botella-Estrada R, Descalzo MA, García-Doval I; BIOBADADERM Study Group.
Descargar documento
-
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
J Dermatolog Treat. 2019 Aug;30(5):461-465. doi: 10.1080/09546634.2018.1535690
Montes-Torres A, Aparicio G, Rivera R, et al. BIOBADADERM Study Group and Psoriasis Group of the AEDV.
Descargar documento
-
Descripción de los pacientes que reciben biológicos como primer tratamiento sistémico en el registro BIOBADADERM durante el periodo 2008-2016
Actas Dermosifiliogr.2018;109:617-23
G. Carretero Hernández, C. Ferrándiz, R. Rivera Díaz, et al.
Descargar documento
-
Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland
Br J Dermatol 2018 May 3. doi: 10.1111/bjd.16715 PMID: 29723914
Garcia-Doval I, Descalzo MA, Mason KJ et al.
Descargar documento
-
Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort.
Br J Dermatol. 2017 Mar;176(3):797-9.PMID: 27120993
Ruiz-Genao D, Perez-Zafrilla B, Lopez-Estebaranz JL, Belinchon-Romero I, Carrascosa JM, Ferran M, et al.
Descargar documento
-
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1021-8. PMID: 28252811
Perez-Plaza A, Carretero G, Ferrandiz C, Vanaclocha F, Gomez-Garcia FJ, Herrera-Ceballos E, et al.
Descargar documento
-
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.
Br J Dermatol. 2017 Mar;176(3):643-9.PMID: 27258623
Garcia-Doval I, Hernandez MV, Vanaclocha F, Sellas A, de la Cueva P, Montero D, et al.
Descargar documento
-
Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries.
J Am Acad Dermatol. 2017 Feb;76(2):299-308 e16. PMID: 27693008
Garcia-Doval I, Cohen AD, Cazzaniga S, Feldhamer I, Addis A, Carretero G, et al.
Descargar documento
-
Manejo de los tratamientos biológicos en pacientes con psoriasis moderada-severa sometidos a intervenciones quirúrgicas en el registro español BIOBADADERM.
Actas Dermosifiliogr. 2017 Jan - Feb;108(1):52-8.PMID: 27658689
Galiano Mejias S, Carretero G, Ferrandiz C, Vanaclocha F, Dauden E, Gomez-Garcia FJ, et al.
Descargar documento
-
Serie de casos de pacientes psoriásicas expuestas a terapia biológica durante el embarazo. Registro BIOBADADERM y revisión de la literatura.
Actas Dermosifiliogr. 2017 Mar;108(2):168-70. PMID: 27765165
Echeverria-Garcia B, Nuno-Gonzalez A, Dauden E, Vanaclocha F, Torrado R, Belinchon I, et al.
Descargar documento
-
Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: a cohort study.
J Am Acad Dermatol. 2017 Nov 13. pii: S0190-9622(17)32683-X. doi: 10.1016/j.jaad.2017.10.051. PubMed PMID: 29146129
Descalzo MA, Carretero G, Ferrándiz C, Rivera R, Daudén E, Gómez-García FJ, de la Cueva P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Baniandrés O, Carrascosa JM, Llamas-Velasco M, Ruiz-Genao D, Herrera-Acosta E, Muñoz-Santos C, García-Doval I; Biobadaderm Study Group.
Descargar documento
-
Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries
Acta Derm Venereol. 2017 Apr 06;97(4):516-8. PMID: 27882386
Davila-Seijo P, Garcia-Doval I, Naldi L, Cazzaniga S, Augustin M, Rustenbach SJ, et al.
Descargar documento
-
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
J Invest Dermatol. 2017 Feb;137(2):313-321. PMID: 27677836
Davila-Seijo P, Dauden E, Descalzo MA, Carretero G, Carrascosa JM, Vanaclocha F, et al.
Descargar documento
-
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1700-8. PMID: 28485816
Belinchon I, Ramos JM, Carretero G, Ferrandiz C, Rivera R, Dauden E, et al.
Descargar documento
-
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the Biobadaderm cohort.
J Dermatol Treat 2016 Jun;27(3):203-9 PMID: 26367799
García-Doval I; B Pérez-Zafrilla ; C Ferrandiz; G Carretero ; E Daudén ; P de la Cueva; FJ Gómez-García ; E Herrera-Ceballos ; I Belinchón-Romero ; JL Sánchez-Carazo; JL López-Estebaranz; M Alsina; M Ferrán; R Torrado; JM Carrascosa et al.
Descargar documento
-
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1942-50. PMID: 27329511
Davila-Seijo P, Dauden E, Carretero G, Ferrandiz C, Vanaclocha F, Gomez-Garcia FJ, et al.
Descargar documento
-
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.
Actas Dermosifiliogr 2015 Jul-Aug;106(6):477-482 PMID: 25776200
Sanz-Bueno J, Vanaclocha F, García-Doval I, Torrado R, Carretero G, Daudén E,Patricia Ruiz-Genao D, Alsina-Gibert MM, Pérez-Zafrilla B, Pérez-Rial G, Rivera R; miembros del grupo BIOBADADERM.
Descargar documento
-
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry
J Eur Acad Dermatol Venereol. 2015 May;29(5):858-64. PMID: 25185962
Medina C, Carretero G, Ferrandiz C, Dauden E, Vanaclocha F, Gomez-Garcia FJ, et al.
Descargar documento
-
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a five year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):156-63 PMID: 24684267
Carretero G, Ferrándiz G, Daudén E, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, et al
Descargar documento
-
Escalera terapéutica en la psoriasis moderada y grave ¿ Sólo hacia arriba?: El porcentaje de pacientes con psoriasis grave tratados con biológicos se incrementa con el tiempo
Actas Dermosifiliográficas 2015;106:638-43 PMID: 26141003
Carrascosa JM, Rivera N, Garcia-Doval I, Carretero G, Vanaclocha F, Daudén E, Gómez-García FJ, De-la-Cueva-Dobao P, Herrera-Ceballos E, Belinchón I, Alsina M, Sánchez-Carazo JL, Ferrán M, Lopez-Estebaranz JL, Pérez-Zafrilla B, Llamas M, Rivera R, et al
Descargar documento
-
Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice
J Dermatol Treat 2015;26(6):502-6. PMID: 25886087
Carrascosa JM, Garcia-Doval I, Perez-Zafrilla B, Carretero G, Vanaclocha F, Dauden E, et al.
Descargar documento
-
Body Mass Index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal. Results of the Biobadaderm Registry.
J Eur Acad Dermatol Venereol. 2014 Jul;28(7):907-14 PMID: 23848131
Carrascosa JM, Vilavella M, Garcia-Doval I, Carretero G, Vanaclocha F, Dauden E, et al.
Descargar documento
-
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain.
J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1366-74.PMID: 23134268
Sanchez-Moya AI, Garcia-Doval I, Carretero G, Sanchez-Carazo J, Ferrandiz C, Herrera Ceballos E, et al.
Descargar documento
-
Systemic psoriasis therapy shows high between-countries variation. A sign of unwarranted variation? Cross-sectional analysis of baseline data from the Psonet registries.
Br J Dermatol. 2013 Sep;169(3):710-4. PMID: 23551034
Garcia-Doval I, Rustenbach SJ, Stern R, Dam TN, Cohen AD, Baker C, Spuls PI, Naldi L; The Psonet Network.
Descargar documento
-
Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials.
Arch Dermatol. 2012 Apr;148(4):463-70. PubMed PMID: 22508869
Garcia-Doval I, Carretero G, Vanaclocha F, Ferrandiz C, Daudén E, Sánchez-Carazo JL, Alsina M, Herrera-Ceballos E, Gómez-García FJ, Ferrán M, López-Estebaranz JL, Hernanz JM, Belinchón-Romero I, Vilar-Alejo J, Rivera R, Carrascosa JM, Carazo C.
Descargar documento
-
BIOBADADERM: registro espanol de acontecimientos adversos de terapias biológicas en Dermatología. Primer informe
Actas Dermosifiliogr. 2011;102(2):132—141. PMID: 21377137
R. Rivera , I. García-Doval, G. Carretero, E. Daudén, J. Sánchez-Carazo, C. Ferrándiz, E. Herrera, M. Alsina, M. Ferrán, J.L. López-Estebaranz, F. Gómez, J.M. Herranz, J.M. Carrascosa y F. Vanaclocha, miembros del grupo BIOBADADERM
Descargar documento